Abstract:Esophageal cancer represents the eighth most frequently occurring cancer, as well as the sixth most widespread cause of cancer-related deaths. In recent years, accumulating evidence has implicated long non-coding RNAs in the progression of esophageal squamous cell carcinoma (ESCC). The aim of the present study was to investigate the potential involvement and underlying mechanisms of LINC00337 in ESCC. Expression patterns of LINC00337 and targeting protein for Xenopus kinesin-like protein 2 (TPX2) in ESCC tissues and cells were detected using RT-qPCR and immunohistochemical staining. Next, the interactions among LINC00337, E2F4, and TPX2 were identified using chromatin immunoprecipitation, dual-luciferase reporter, and RNA-binding protein immunoprecipitation assays, suggesting that LINC00337 could recruit E2F4 to enhance the transcription of TPX2. Thereafter, the regulatory roles of LINC00337 and TPX2 in ESCC were analyzed by altering the expression of LINC00337 or TPX2 in ESCC cells following treatment with cisplatin (DDP). The levels of autophagy-related proteins Beclin1 and LC3II/LC3I, viability, autophagy, apoptosis, and chemoresistance of ESCC cells to DDP were measured following transfection treatment with different plasmids. Additionally, the role of the LINC00337/E2F4/TPX2 axis was assessed in vivo by measuring tumor formation in nude mice. The results demonstrated that LINC00337 upregulated TPX2, consequently leading to elevated levels of Beclin1 and LC3II/LC3I, promoted cell viability and autophagy, while inhibiting apoptosis and chemosensitivity to DDP in ESCC. In sum, the current study evidenced that the overexpression of LINC00337 could potentially enhance ESCC cell autophagy and chemoresistance to DDP via the upregulation of TPX2 by recruiting E2F4. Thus, LINC00337 may serve as a potential candidate for the treatment of ESCC.

XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo

Genome-scale CRISPR Activation Screening Identifies a Role of ELAVL2-CDKN1A Axis in Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma.

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Effects and Underlying Mechanisms of Homologous Recombina-Tion-associated Protein XRCC3 on Esophageal Squamous-Cell Carci-Noma Radiotherapy Response

DNA Methylation Enzyme Inhibitor RG108 Suppresses the Radioresistance of Esophageal Cancer

shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo.

Single-cell Transcriptome Analyses Reveal Molecular Signals to Intrinsic and Acquired Paclitaxel Resistance in Esophageal Squamous Cancer Cells

Xrcc2 As A Predictive Biomarker for Radioresistance in Locally Advanced Rectal Cancer Patients Undergoing Preoperative Radiotherapy

Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4

Targeting Protein for Xenopus Kinesin-Like Protein 2 Knockdown Enhances Radiation Sensitivity of Human Lung Squamous Carcinoma Cell

RNA-seq Reveals Determinants of Sensitivity to Chemotherapy Drugs in Esophageal Carcinoma Cells.

Pharmacological Inhibition of PP2A Overcomes Nab-Paclitaxel Resistance by Downregulating MCL1 in Esophageal Squamous Cell Carcinoma (ESCC)

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy

The ATPase Subunit of ATP6V1C1 Inhibits Autophagy and Enhances Radiotherapy Resistance in Esophageal Squamous Cell Carcinoma.

XRCC2 Promotes Colorectal Cancer Cell Growth, Regulates Cell Cycle Progression, and Apoptosis

High-mobility group box 1 protein modulated proliferation and radioresistance in esophageal squamous cell carcinoma

Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

Overexpression of Xeroderma Pigmentosum Group C Decreases the Chemotherapeutic Sensitivity of Colorectal Carcinoma Cells to Cisplatin

The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma